|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 257, Issue 6 1423-R1428, Copyright © 1989 by American Physiological Society
ARTICLES |
M. W. Brands and R. H. Freeman
Department of Physiology, University of Missouri School of Medicine, Columbia 65212.
This study was designed to determine the effects of synthetic rat atrial natriuretic factor (ANF) on plasma renin activity (PRA) and aldosterone secretion in separate groups of normal and potassium-loaded anesthetized rats. Control rats were fed a normal diet of sodium and potassium and had base-line levels of PRA and aldosterone secretion of 25 +/- 3 ng angiotensin I (ANG I).ml-1.h-1 and 0.56 +/- 0.09 ng/min, respectively. Chronic oral potassium loading for 10 days elevated the plasma potassium concentration, stimulated aldosterone secretion to 1.80 +/- 0.18 ng/min (P less than 0.05), and attenuated PRA to 13 +/- 2 ng ANG I.ml-1.h-1 (P less than 0.05). Infusion of ANF at 45 ng.kg-1.min-1 in potassium-loaded rats lowered aldosterone secretion to 1.32 +/- 0.21 ng/min (P less than 0.05) but did not significantly reduce PRA (11 +/- 2 ng ANG I.ml-1.h-1 (P greater than 0.05). A higher ANF infusion dose of 100 ng.kg-1.min-1 produced a further decrement in aldosterone secretion to 1.15 +/- 0.26 ng/min (P less than 0.05) and also reduced PRA to 3 +/- 1 ng ANG I.ml-1.h-1 (P less than 0.05). In the control rats, aldosterone secretion and PRA were decreased significantly during infusion with both low and high ANF doses. Base-line arterial pressures among experimental groups were not different (P greater than 0.05) and did not change during infusion of ANF in any group. These results indicate that ANF can inhibit chronic potassium-stimulated aldosterone secretion in the rat independently of its inhibitory actions on renin release.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |